Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 7/20 | 0.56 |
| ▸ | ME2 | P23368 | 1/20 | 0.47 |
| ▸ | ME1 | P48163 | 1/20 | 0.47 |
| ▸ | ME3 | Q16798 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6023956 | 0.96 | MEN1 (0.62) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6023056 | 0.95 | ACHE (0.54) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6022869 | 0.84 | ACHE (0.55) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6022672 | 0.82 | ACHE (0.54) | MEN1KMT2ATHRBACHE | |
| SCHEMBL6022488 | 0.81 | MEN1 (0.47) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6022619 | 0.81 | MEN1 (0.47) | MEN1KMT2ATHRBACHEME2 | |
| Hydrochloric Acid SCHEMBL6022951 | 0.81 | MEN1 (0.46) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6022474 | 0.79 | MEN1 (0.46) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6023985 | 0.79 | MEN1 (0.50) | MEN1KMT2ATHRBACHEME2 | |
| SCHEMBL6022609 | 0.79 | MAPT (0.47) | MEN1KMT2ATHRBACHENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7078407-B2 | 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2006-07-18 | — | — | US | disclosed |
| US-20030162789-A1 | 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162789-A1 | 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them | HTT, PARK7, NQO1 | MEN1 3297/4885KMT2A 1377/4885THRB 4695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.